← Back to screener

HAEMONETICS CORP HAE

Rank #1494 · NYSE · $5.4B market cap
Audited by Ernst & Young LLP, no going-concern flag in the latest filing.
Score
47.5
P/E
46.3
P/B
6.65
ROE
14.4%
Op. Margin
12.6%
Debt Ratio
200%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★☆☆☆
Weak

P/E 46.3x, P/B 6.65x. Ranks in the top 62% of the universe.

Profitability ★★★☆☆
Good

ROE 14.4%. Ranks in the top 34% of the universe.

Safety ★★☆☆☆
Weak

Debt ratio 200%. Ranks in the top 62% of the universe.

Growth ★★★★☆
Good

Revenue growth of 12.0% year over year. Ranks in the top 30% of the universe.

Growth is the relative strength · Valuation is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2011$0.6B$0.1B$0.1B$0.5B12.942
2012$0.7B$0.1B$0.1B$0.6B16.340
2013$0.7B$0.1B$0.1B$0.7B12.233
2015$0.9B$0.1B$0.0B$0.7B6.3100
2016–$0.0B$0.0B$0.8B–93
2017–$0.0B$0.0B$0.8B–57
2018–$-0.0B$-0.1B$0.8B–50
2019$0.9B$-0.0B$-0.0B$0.7B-2.271
2020$0.9B$0.1B$0.0B$0.7B6.272
2021$1.0B$0.1B$0.1B$0.8B8.668
2022$1.0B$0.1B$0.1B$0.7B10.5172
2023$0.9B$0.1B$0.1B$0.6B10.3217
2024$1.0B$0.1B$0.0B$0.7B8.1164
2025$1.2B$0.2B$0.1B$0.7B13.4193
2026$1.3B$0.2B$0.1B$0.8B12.6200

← See the full screener